ZA715851B - Process for preparing 2-substituted-5-sulfamyl-benzoic acids - Google Patents

Process for preparing 2-substituted-5-sulfamyl-benzoic acids

Info

Publication number
ZA715851B
ZA715851B ZA715851A ZA715851A ZA715851B ZA 715851 B ZA715851 B ZA 715851B ZA 715851 A ZA715851 A ZA 715851A ZA 715851 A ZA715851 A ZA 715851A ZA 715851 B ZA715851 B ZA 715851B
Authority
ZA
South Africa
Prior art keywords
sulfamyl
substituted
preparing
benzoic acids
benzoic
Prior art date
Application number
ZA715851A
Other languages
English (en)
Inventor
G Holland
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA715851B publication Critical patent/ZA715851B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA715851A 1970-09-14 1971-09-01 Process for preparing 2-substituted-5-sulfamyl-benzoic acids ZA715851B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7215670A 1970-09-14 1970-09-14

Publications (1)

Publication Number Publication Date
ZA715851B true ZA715851B (en) 1972-05-31

Family

ID=22105942

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA715851A ZA715851B (en) 1970-09-14 1971-09-01 Process for preparing 2-substituted-5-sulfamyl-benzoic acids

Country Status (14)

Country Link
JP (1) JPS5512422B1 (nl)
AT (1) AT323187B (nl)
AU (1) AU468590B2 (nl)
BE (1) BE772381A (nl)
CA (1) CA983489A (nl)
CH (2) CH552575A (nl)
ES (2) ES394830A1 (nl)
FR (1) FR2106514B1 (nl)
GB (1) GB1353357A (nl)
KE (1) KE2573A (nl)
MY (1) MY7500253A (nl)
NL (1) NL173400C (nl)
SE (1) SE401673B (nl)
ZA (1) ZA715851B (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929803A (en) * 1974-05-28 1975-12-30 Pfizer Aryl carboxylic acids
WO1983000013A1 (en) * 1980-11-10 1983-01-06 Mochida Pharm Co Ltd Medicinal composition having an antiviral effect
SE8203877L (sv) * 1981-06-22 1982-12-23 Hodogaya Chemical Co Ltd Aminosulfonylbensoesyraderivat
EP0132540A1 (en) * 1981-06-22 1985-02-13 Mochida Pharmaceutical Co., Ltd. Antiviral compositions
JPS58192863A (ja) * 1982-05-06 1983-11-10 Hodogaya Chem Co Ltd 新規アミノスルホニル安息香酸エステル誘導体
JPS6323210U (nl) * 1986-07-31 1988-02-16
DE3732374A1 (de) * 1987-09-25 1989-04-06 Basf Lacke & Farben Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel
JPH0248510U (nl) * 1988-09-28 1990-04-04
EP1218341B1 (de) * 1999-09-01 2005-08-24 Aventis Pharma Deutschland GmbH Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE19941559A1 (de) * 1999-09-01 2001-03-15 Aventis Pharma Gmbh Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433378A (de) * 1962-03-09 1967-04-15 Ciba Geigy Verfahren zur Herstellung neuer Anthranilsäurederivate
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques

Also Published As

Publication number Publication date
CH569706A5 (nl) 1975-11-28
AT323187B (de) 1975-06-25
SE401673B (sv) 1978-05-22
ES421977A1 (es) 1976-05-01
BE772381A (fr) 1972-03-09
GB1353357A (en) 1974-05-15
MY7500253A (en) 1975-12-31
AU468590B2 (en) 1976-01-15
DE2145686B2 (de) 1977-07-07
FR2106514A1 (nl) 1972-05-05
KE2573A (en) 1975-10-31
NL173400B (nl) 1983-08-16
NL173400C (nl) 1984-01-16
FR2106514B1 (nl) 1975-08-01
CA983489A (en) 1976-02-10
NL7112598A (nl) 1972-03-16
AU3308471A (en) 1973-03-08
JPS5512422B1 (nl) 1980-04-02
ES394830A1 (es) 1974-12-01
DE2145686A1 (de) 1972-04-20
CH552575A (fr) 1974-08-15

Similar Documents

Publication Publication Date Title
PH11550A (en) Process for the preparation of 7-acyl-3-cephem-4-carboxylic acids
YU34671B (en) Process for preparing novel substituted phenyl-2-pyrrolidones
JPS53149921A (en) Process for preparing diesterdiamide
ZA715851B (en) Process for preparing 2-substituted-5-sulfamyl-benzoic acids
YU36482B (en) Process for preparing phenylaminoalkanes
YU70171A (en) Process for preparing n-methylazoles
ZA711022B (en) Process for preparing novel substituted quinoxaline-di-oxides
JPS53116397A (en) Process for preparing imidazoleeribocyclophosphate
IL36143A0 (en) Process for preparing n-alkyl-dimethylamines
JPS5416434A (en) Process for preparing unsaturated esters
YU248971A (en) Process for preparing 1-aminoalkane-1,1-diphosphic acids
YU185578A (en) Process for preparing l-delta-hydrazino-beta-phenylpropionic acid
IL37827A (en) Process for preparing substituted cobamides
YU268371A (en) Process for preparing delta-substituted 2-aminomethylbenzylalcohols
YU25671A (en) Process for preparing des-phenylalanine-bi-insulin
YU52071A (en) Process for preparing 9delta-chloro-11b-hydroxy-3-keto-4-pregnenes
ZA713885B (en) Process for preparing triketoimidazolidines
ZA717077B (en) Process for preparing osaziridines
YU185878A (en) Process for preparing l-delta-hydrazino-beta-phenylpropionic acid
YU260071A (en) Process for preparing novel quinazolone-diurethanes
YU195871A (en) Process for preparing thiadiazolyl-carbamides
YU185678A (en) Process for preparing l-delta-hydrazino-beta-phenylpropionic acid
YU35351B (en) Process for preparing novel substituted phenyl-thiolcarbamates
YU306471A (en) Process for preparing wlkylarylsulfoxides
YU34535B (en) Process for preparing 3-acetyl-steroids